References
- amfAR: The Foundation for AIDS Research. (2014). Trans population and HIV: Time to end the neglect. Retrieved from http://www.amfar.org/issue-brief-trans-populations-and-hiv-time-to-end-the-neglect/
- Ayres, L., Kavanaugh, K., & Knafl, K. A. (2003). Within-case and across-case approaches to qualitative data analysis. Qualitative Health Research, 13(6), 871–883. doi: 10.1177/1049732303013006008
- Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., … Celum, C. (2012, August 2). Antiretroviral prophylaxis for HIV-1 prevention among heterosexual men and women. New England Journal of Medicine, 367(5), 399–410. doi: 10.1056/NEJMoa1108524
- Baral, S. D., Poteat, T., Stromdahl, S., Wirtz, A. L., Guadamuz, T. E., & Beyrer, C. (2013). Worldwide burden of HIV in transgender women: A systematic review and meta-analysis. The Lancet Infectious Diseases, 13(3), 214–222. doi: 10.1016/S1473-3099(12)70315-8
- Bradford, J., Reisner, S., Honnold, J., & Xavier, J. (2013). Experiences of transgender-related discrimination and implications for health: Results from the Virginia transgender health Initiative study. American Journal of Public Health, 103(10), 1820–1829. doi: 10.2105/AJPH.2012.300796
- Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., … Bangkok Tenofovir Study Group. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet, 381(9883), 2083–2090. doi:10.1016/S0140-6736(13)61127-7
- Community Healthcare Network: Special Programs. (2017). Transgender Women Entry and Engagement to Care (TWEET) Project. Retrieved from http://www.chnnyc.org/patients/special-programs/transgender-women-entry-and-engagement-to-care-tweet-project
- Deutsch, M. B., Glidden, D. V., Sevelius, J., Keatley, J., McMahan, V., Guanira, J., … Grant, R. (2015, November 5). HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial. The Lancet, 2(12), e512–e519. doi: 10.1016/S2352-3018(15)00206-4
- Goldstein, R. H., Streed, C. G., & Cahill, S. R. (2018, September 19). Be PrEPared—preexposure prophylaxis and HIV Disparities. New England Journal of Medicine, 379(14), 1293–1295. doi: 10.1056/NEJMp1804306
- Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599. doi: 10.1056/NEJMoa1011205
- Highleyman, L. (2018, August 13). Hormone levels not affected by PrEP in trans women. Beta Blog. Retrieved from https://betablog.org/hormone-levels-not-affected-by-prep-in-trans-women/
- James, S. E., Herman, J. L., Rankin, S., Keisling, M., Mottet, L., & Anafi, M. (2016). The report of the 2015 U.S. Transgender survey. Washington, DC: National Center for Transgender Equality. Retrieved from http://www.transequality.org/sites/default/files/docs/usts/USTS20Full20Report20-20FINAL%201.6.17.pdf
- Joint Commission. (2011). Advancing effective Communication, Cultural Competence, and patient- and Family-Centered care for the lesbian, gay, bisexual, and transgender (LGBT) community: A field guide. Oak Brook, IL: Joint Commission Resources. Retrieved from http://www.jointcommission.org/assets/1/18/LGBTFieldGuide.pdf
- Kaiser Family Foundation. (2018). Current status of state Medicaid expansion decisions (map). Retrieved from https://www.kff.org/health-reform/slide/current-status-of-the-medicaid-expansion-decision/
- No author. (n.d.). Healthy Divas Intervention Manual. San Francisco: Center of Excellence for Transgender Health, University of California San Francisco. Retrieved from https://careacttarget.org/sites/default/files/Healthy%20Divas%20Intervention%20Manual.pdf
- Nuttbrock, L., Hwahng, S., Bockting, W., Rosenblum, A., Mason, M., Macri, M., & Becker, J. (2009). Lifetime risk factors for HIV/sexually transmitted infections among male-to-female transgender persons. JAIDS Journal of Acquired Immune Deficiency Syndromes, 52(3), 417–421. doi: 10.1097/QAI.0b013e3181ab6ed8
- Phillippi, J., & Lauderdale, J. (2018). A guide to field notes for qualitative research: Context and conversation. Qualitative Health Research, 28(3), 381–388. doi: 10.1177/1049732317697102
- Reisner, S. L., White Hughto, J. M., Dunham, E., Heflin, K., Begenyi, J. B., Coffey-Esquivel, J., & Cahill, S. (2015). Legal protections in public accommodations settings: A critical public health issue for transgender and gender nonconforming people. Milbank Quarterly, 93(3), 484–515. doi: 10.1111/1468-0009.12127
- Reisner, S., White Hughto, J., Gamarel, K., Keuroghlian, A., Mizock, L., & Pachankis, J. (2016). Discriminatory experiences associated with posttraumatic stress disorder symptoms among transgender adults. Journal of Counseling Psychology, 63(5), 509–519. doi: 10.1037/cou0000143
- Sandelowski, M. (2010). What’s in a name? Qualitative description revisited. Research in Nursing and Health, 33, 77–84.
- Sevelius, J., Carrico, A., & Johnson, M. (2010). Antiretroviral therapy adherence among transgender women living with HIV. Journal of the Association of Nurses in AIDS Care, 21(3), 256–264. doi: 10.1016/j.jana.2010.01.005
- Sevelius, J. M., Deutsch, M., & Grant, R. (2016). The future of PrEP among transgender women: The critical role of gender affirmation in research and clinical practices. Journal of the International AIDS Society, 19(Suppl 6), 21105. doi: 10.7448/IAS.19.7.21105
- Sevelius, J., Patouhas, E., Keatley, J., & Johnson, M. (2014). Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Annals of Behavioral Medicine, 47(1), 5–16. doi: 10.1007/s12160-013-9565-8
- Substance Abuse and Mental Health Services Administration. (2014). SAMHSA’s Concept of Trauma and Guidance for a Trauma-Informed Approach. Retrieved from https://store.samhsa.gov/shin/content/SMA14-4884/SMA14-4884.pdf
- Sullivan-Bolyai, S., Boya, C., & Harper, D. (2005). Developing and refining interventions in persons with health disparities: The use of qualitative description. Nursing Outlook, 53(3), 127–133. doi: 10.1016/j.outlook.2005.03.005
- UNAIDS. (2013). Global report: UNAIDS report on the global AIDS epidemic 2013. Retrieved from http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Global_Report_2013_en_1.pdf
- U.S. CDC. (2015). HIV among transgender women [Fact sheet]. Retrieved from http://www.cdc.gov/hiv/risk/transgender/
- Volpi, C., & Cahill, S. (2018, April). Retaining transgender women in HIV care: Best practices in the field. Boston: The Fenway Institute.
- White Hughto, J., Reisner, S., & Pachankis, J. (2015). Transgender stigma and health: A critical review of stigma determinants, mechanisms, and interventions. Social Science & Medicine, 147, 222–231. doi: 10.1016/j.socscimed.2015.11.010